Literature DB >> 22926639

Molecular-targeted therapies for ovarian cancer.

Junzo Kigawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22926639     DOI： 10.1007/s10147-012-0456-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  3 in total

1.  Bevacizumab and cancer treatment-related mortality.

Authors:  Cornelis J A Punt; Linda Mol; Miriam Koopman
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

2.  Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action.

Authors:  Hiroaki Itamochi
Journal:  World J Biol Chem       Date:  2010-07-26

3.  Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Authors:  Michael A Bookman; Mark F Brady; William P McGuire; Peter G Harper; David S Alberts; Michael Friedlander; Nicoletta Colombo; Jeffrey M Fowler; Peter A Argenta; Koen De Geest; David G Mutch; Robert A Burger; Ann Marie Swart; Edward L Trimble; Chrisann Accario-Winslow; Lawrence M Roth
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544
  3 in total
  1 in total

Review 1.  New strategy for overcoming resistance to chemotherapy of ovarian cancer.

Authors:  Junzo Kigawa
Journal:  Yonago Acta Med       Date:  2013-07-12       Impact factor: 1.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.